Powder: -20°C for 3 years | In solvent: -80°C for 1 year
3β-Hydroxy-urs-11-en-28,13β-olide shows a potent concentration-independent cytoprotective effect against CCl4-induced injury on human hepatoma cell line relative to silymarin as a reference standard. It exhibits weak-moderate antiproliferative activity against the A2780 human ovarian cancer cell line.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 612.00 |
Description | 3β-Hydroxy-urs-11-en-28,13β-olide shows a potent concentration-independent cytoprotective effect against CCl4-induced injury on human hepatoma cell line relative to silymarin as a reference standard. It exhibits weak-moderate antiproliferative activity against the A2780 human ovarian cancer cell line. |
Source |
Molecular Weight | 454.695 |
Formula | C30H46O3 |
CAS No. | 35959-05-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
3-Hydroxy-11-ursen-28,13-olide 35959-05-8 Others 3 Hydroxy 11 ursen 28,13 olide 3Hydroxy11ursen28,13olide inhibitor inhibit